logo
Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices
Interferon-α generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection
Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression
Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART
Mitochondrial involvement in antiretroviral therapy-related lipodystrophy
Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8–18 months of antiretroviral therapy in acutely infected patients
Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients
Intracellular cytokines in the acute response to highly active antiretroviral therapy
World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz
Direct analysis of mitochondrial toxicity of antiretroviral drugs
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
Factors influencing the difference in HIV prevalence between antenatal clinic and general population in sub-Saharan Africa
Access to antiretroviral therapy in HIV-infected injection drug users
Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients
Reduced bone mineral density in HIV-positive individuals
Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens
Impact of protease inhibitors on intrahepatic hepatitis C virus viral load
Tuberculosis preventative therapy as part of a care package for people living with HIV in a district of Thailand
‘Behind walls’: a study of HIV risk behaviours and seroprevalence in prisons in Zambia
Reply to ‘Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis’ by Holmberg and Moorman
Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children
Sildenafil in HIV-related pulmonary hypertension